Home
>
National Drug Code (NDC)
>
POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE
POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE - 52959-609-10 - (polymyxin B sulfate, trimethoprim sulfate)
Drug Information of POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE
| Product NDC: | 52959-609 |
| Proprietary Name: | POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE |
| Non Proprietary Name: | polymyxin B sulfate, trimethoprim sulfate |
| Active Ingredient(s): | 10000; 1 [USP'U]/mL; mg/mL & nbsp; polymyxin B sulfate, trimethoprim sulfate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE
| Product NDC: | 52959-609 |
| Labeler Name: | H.J. Harkins Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050567 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 19970429 |
Package Information of POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE
| Package NDC: | 52959-609-10 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (52959-609-10) > 10 mL in 1 BOTTLE, DROPPER |
NDC Information of POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE
| NDC Code | 52959-609-10 |
| Proprietary Name | POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (52959-609-10) > 10 mL in 1 BOTTLE, DROPPER |
| Product NDC | 52959-609 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | polymyxin B sulfate, trimethoprim sulfate |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19970429 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | H.J. Harkins Company, Inc. |
| Substance Name | POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE |
| Strength Number | 10000; 1 |
| Strength Unit | [USP'U]/mL; mg/mL |
| Pharmaceutical Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
